Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe

por Baraliakos, Xenofon, Witte, Torsten, De Clerck, Luc, Frediani, Bruno, Collantes-Estévez, Eduardo, Katsifis, Gkikas, VanLunen, Brenda, Kleine, Elisabeth, Hoepken, Bengt, Bauer, Lars, Goodson, Nicola
Publicado 2020